Abramson Cancer Center at University of Pennsylvania — Philadelphia, Pennsylvania

Abramson Cancer Center at University of Pennsylvania is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Abramson Cancer Center at University of Pennsylvania has participated in 24 clinical trials with 12 currently active.

Therapeutic areas: Melanoma, Advanced Melanoma, Myeloma Multiple.

Sponsors: Abramson Cancer Center at Penn Medicine, Ryan Carey, Ravi Amaravadi, MD.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center at University of Pennsylvania?

Abramson Cancer Center at University of Pennsylvania has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center at University of Pennsylvania conducted?

Abramson Cancer Center at University of Pennsylvania has 24 clinical trials on record, with 12 currently active. Their work covers Melanoma, Advanced Melanoma, Myeloma Multiple.

Is Abramson Cancer Center at University of Pennsylvania accredited by Crixeo Health?

Yes — Abramson Cancer Center at University of Pennsylvania holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Abramson Cancer Center at University of Pennsylvania?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.